Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P15088 (
mast cell
)
14,925
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The effect of immunoglobulin E (IgE)-mediated anaphylaxis has been extensively studied in the small intestine, but little information is available on the response of the stomach to IgE-mediated mucosal reactions to food proteins. The effect of luminal antigenic challenge on gastric acid secretion, gastric emptying, and mucosal
mast cell
degranulation was examined in rats sensitized to egg albumin or in sham-treated controls. Intraluminal challenge of the stomach with egg albumin in sensitized animals significantly increased gastric acid secretion and delayed gastric emptying. The response was specific for the sensitizing antigen as challenge with bovine serum albumin was without effect. Sham-treated animals showed no response to egg albumin or bovine serum albumin. The increase in gastric acid secretion was reproduced by antigen challenge in naive animals passively transferred with hyperimmune serum. This effect was abolished by prior heat treatment of the serum. In sensitized animals challenged with egg albumin, there was histological evidence of
mast cell
degranulation in the stomach mucosa, increased intraluminal release of histamine, and increased serum levels of
rat mast cell protease II
, a marker specific for mucosal
mast cell
degranulation. The findings indicate that the stomach is a target organ for IgE-mediated reactions to food proteins. Antigen challenge in sensitized animals leads to increased gastric acid secretion and delayed emptying and evidence of mucosal
mast cell
activation.
...
PMID:Gastric response to mucosal IgE-mediated reactions. 259 6
Mast cells at immature stages of development were identified in human tissues by electron microscopic techniques. General morphologic criteria of immaturity (such as a high apparent nuclear:cytoplasmic ratio and small cell size), the presence of few granules (those present being smaller than those in mature mast cells) and a lack of features of
mast cell
activation were used together to determine the level of maturity. Mast cells were identified as being of the T or TC type by immunogold staining with polyclonal rabbit IgG anti-chymase and murine monoclonal anti-
tryptase
primary antibodies and the appropriate gold-labeled secondary antibodies. Only those cells with
tryptase
-positive granules were recognized as mast cells. Immature T
mast cell
granules contained the same characteristic discrete scrolls found in their mature counterparts and all stained positive for
tryptase
. The presence of trace amounts of chymase in a minority of these granules, as in mature T mast cells, could not be ruled out. The majority of granules in immature TC mast cells had one or more amorphous electron-dense cores rather than the grating and lattice substructures characteristic of granules in mature TC mast cells. Secretory granules in immature TC mast cells stained positively for
tryptase
and chymase. Occasional immature TC mast cells contained a complete granule or a portion of a granule with the substructure characteristic of mature TC mast cells, favoring the concept that these TC
mast cell
forms are developmentally related. Essentially all mast cells in foreskin of newborns appeared immature, whereas 10, 5, 10, and 15% of the mast cells in adult lung, foreskin, bowel mucosa and bowel submucosa, respectively, appeared immature. The distribution of T and TC types of immature mast cells seemed to parallel that of the mature
mast cell
types. These compositional and ultrastructural differences between immature T and TC types of mast cells suggest that from the time granule formation begins, and possibly before this time, each type of human
mast cell
follows a distinct developmental pathway.
...
PMID:Ultrastructural analysis of maturing human T and TC mast cells in situ. 264 87
We tested four synthetic substances for their histochemical value to demonstrate the catalytic activities of chymase or
tryptase
in mast cells in sections of human gut. Both Suc-Ala-Ala-Phe-4 methoxy-2-naphthylamide (MNA) and N-acetyl-L-methionine-alpha-naphthyl ester (alpha-N-O-Met) reacted with chymase but not
tryptase
in mast cells. Conversely, D-Val-Leu-Arg-MNA and Z-Ala-Ala-Lys-MNA were hydrolyzed by
mast cell tryptase
but not chymase. These results were confirmed by use of two inhibitors of chymotrypsin-like activity, chymostatin and Z-Gly-Leu-Phe-chloromethyl ketone (CK) and two inhibitors of trypsin-like activity, Tos-Lys-CK and D-Val-Leu-Arg-CK. Excellent staining reactions were obtained on cryostat sections of unfixed or aldehyde-fixed tissues and on paraffin sections of Carnoy-fixed tissues. For chymase, however, Suc-Ala-Ala-Phe-MNA is preferred on cryostat sections because it is more specific. On paraffin sections alpha-N-O-Met is preferred because other cells are not then stained. For
tryptase
, Z-Ala-Ala-Lys-MNA was more selective and more specific and is the preferred general purpose substrate on cryostat sections of aldehyde-fixed tissues and for paraffin sections. D-Val-Leu-Arg-MNA is the preferred substrate for cryostat sections of unfixed tissue. Only a limited number of mast cells showed a reaction for chymase, and these occurred mainly in the submucosa. All mast cells, however, gave a reaction for
tryptase
, and we recommend the use of either substrate for this enzyme for routine detection of mast cells in human tissues. Double staining for the two main
mast cell
proteases is most conveniently undertaken on paraffin sections of Carnoy-fixed tissues using MNA substrates for
tryptase
and alpha-N-O-Met for chymase.
...
PMID:Enzyme histochemical discrimination between tryptase and chymase in mast cells of human gut. 264 38
Tryptase
from human mast cells is stabilized by negatively charged macromolecules such as heparin and is not affected by the protein inhibitors of serine proteinases normally present in human extracellular fluids. The current study demonstrated inhibition of
tryptase
-catalyzed cleavage of tosyl-Gly-Pro-Lys-p-nitroanilide by histamine and calcium, and destablization only by calcium. Calcium-mediated inhibition was competitive with a Ki of 30 mM. Cooperation of calcium with other extracellular cations or concentrations of calcium possible within cells or granules may permit calcium-mediated inhibition to occur in vivo. In contrast, only 5 mM calcium is needed to cause an irreversible 50% loss of
tryptase
activity after 60 min at room temperature. Histamine and N-methyl histamine concentrations of 2 mM to 10 mM inhibited
tryptase
activity by a different mechanism than calcium, resulting in sigmoid rather than hyperbolic kinetics. Whether this reflects cooperative binding of histamine to
tryptase
or conformational alterations of
tryptase
is not known. These concentrations of histamine are most relevant to those in
mast cell
secretory granules estimated at 100 mM, where
tryptase
is stored fully active and where histamine may play a role in attenuating
tryptase
activity.
...
PMID:Effect of histamine and divalent cations on the activity and stability of tryptase from human mast cells. 265 89
The
mast cell
proteases
tryptase
and chymase have long been known to constitute one-fifth of the total protein in mast cells. However, their biological functions have not been easy to study because of the difficulty in obtaining sufficient amounts of the enzymes to study their biological functions. Recently, we have been fortunate to have available a permanent line of dog mastocytoma cells to purify both enzymes to homogeneity, and we have used the purified enzymes in two ways. First, in a series of biological studies, we have discovered unique and potent actions of the enzymes that may provide important insights into the pathogenesis of diseases such as asthma and cystic fibrosis. Important biological activities are also likely to exist in other tissues. Because of their structures,
mast cell
proteases are likely to act in proximity to their sites of release. Thus, the presence and amounts of
tryptase
and chymase in specific loci may play important roles in tissue responses. In diseases such as asthma and cystic fibrosis, there is evidence that the expression of these
mast cell
enzymes changes, and these changes have important pathogenetic implications. Second, we have begun to perform structural studies of the enzymes. The recent cloning of
tryptase
by our group should assist in the better understanding of its functions. Crystallography of the pure proteins should provide further insights and could be the basis of rational development of potent and selective drugs that will inhibit their actions.
...
PMID:Roles of mast cell proteases in airways. 266 41
Mast cells are abundant and are widely distributed in airway tissues. They release their secretory products into microenvironments as diverse as epithelium, smooth muscle, and glands. The major secretory granule proteins of mast cells are proteases that are released outside of the cell with heparin, histamine, and other preformed mediators. In the past few years, investigations in a number of laboratories have rapidly increased our knowledge of the chemical and biological properties of the two major
mast cell
secretory proteases,
tryptase
and chymase. Recent experimental evidence suggests the possibility of biologically important roles for
tryptase
and chymase in the airways, particularly in the regulation of neuropeptide activity, bronchomotor tone, and submucosal gland secretion. The purpose of this commentary is to examine critically the evidence of participation of these
mast cell
proteases in molecular and physiological events in the airways.
...
PMID:Roles of mast cell tryptase and chymase in airway function. 266 22
The amino acid sequence of human
mast cell tryptase
was determined from corresponding cDNA cloned from a lambda ZAP library made with mRNA derived from a human
mast cell
preparation.
Tryptase
is the major neutral protease present in human mast cells and serves as a specific marker of mast cells by immunohistologic techniques and as a specific indicator of
mast cell
activation when detected in biologic fluids. Based on nucleic acid sequence, human
tryptase
consists of a 244-amino acid catalytic portion of 27,423 D with two putative N-linked carbohydrate binding sites and a 30-amino acid leader sequence of 3,048 D. A His74, Asp120, Ser223 catalytic triad and four cystine groups were identified by analogy to other serine proteases. Regions of amino acid sequence that are highly conserved in serine proteases, in general, were conserved in
tryptase
. The catalytic portion of human
tryptase
had an 84% amino acid sequence similarity with that of dog
tryptase
; their leader sequences had a 67% similarity. Asp217 in the substrate binding pocket of human
tryptase
is consistent with a specificity for Arg and Lys residues at the site of cleavage (P1), whereas Glu245 is consistent with the known preference of human
tryptase
for substrates with Arg or Lys also at P3, analogous residues also being present in dog
tryptase
. Asp244, which is substituted for the Gly found in dog
tryptase
and in most serine proteases, is present in the putative substrate binding pocket and may confer additional substrate specificity on human
tryptase
for basic residues. Further studies now can be designed to elucidate these structure-function relationships.
...
PMID:Cloning and characterization of complementary DNA for human tryptase. 267 49
Mast cell neutral proteases are distinctive markers of the MC(T) and MC(TC) cells in humans. Measurements of
tryptase
levels in vivo serve as an overall indicator of
mast cell
activity. Further research is needed to evaluate the functional role of these proteases as well as each
mast cell
type in situations related to both health and disease.
...
PMID:Human mast cell proteases and mast cell heterogeneity. 267 12
We examined mucosal injury in the jejunum of the rat during infection with the nematode parasite, Nippostrongylus brasiliensis (Nb). Injury was documented morphologically (increase in crypt length with or without villus atrophy) and biochemically (activities of digestive or proliferative enzymes) and related to
mast cell
activation and leukotriene generation. At day 4 crypt length and thymidine kinase activity were increased; no changes in villus parameters were recorded. No evidence of
mast cell
activation was found and leukotriene levels in the mucosa were normal. At day 7, the gut was acutely inflamed and edema was present at the tips of the villi. This progressed to enterocyte detachment, resulting in villus atrophy with decreased activities of brush border enzymes. At this stage mucosal histamine was decreased and
rat mast cell protease II
(RMCP II) was increased in serum, indicating
mast cell
activation. In addition, mucosal leukotrienes (LTB4, LTC4, LTE4) were present in significant quantities. Following worm expulsion, the villus abnormalities resolved and serum RMCP II returned to normal. However, the crypt hyperplasia persisted. Our results suggest that during Nb infection at least two components of injury can be identified. One component, epithelial injury at the villus tips, may be related to activation of mucosal mast cells.
...
PMID:Intestinal mucosal injury is associated with mast cell activation and leukotriene generation during Nippostrongylus-induced inflammation in the rat. 271 47
Antigen (egg albumin) injections, which stimulate mucosal mast cells to secrete mediators, were paired with an audiovisual cue. After reexposure to the audiovisual cue, a mediator (
rat mast cell protease II
) was measured with a sensitive and specific assay. Animals reexposed to only the audiovisual cue released a quantity of protease not significantly different from animals reexposed to both the cue and the antigen; these groups released significantly more protease than animals that had received the cue and antigen in a noncontingent manner. The results support a role for the central nervous system as a functional effector of
mast cell
function in the allergic state.
...
PMID:Pavlovian conditioning of rat mucosal mast cells to secrete rat mast cell protease II. 291 21
<< Previous
1
2
3
4
5
6
7
8
9
10